Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target.
In: Molecular Medicine Reports, Jg. 20 (2019-08-01), Heft 2, S. 1488-1498
academicJournal
Zugriff:
Fibrosis is characterized by excessive extracellular matrix (ECM) deposition, and is the pathological outcome of tissue injury in a number of disorders. Accumulation of the ECM may disrupt the structure and function of native tissues and organs, including the lungs, heart, liver and skin, resulting in significant morbidity and mortality. On this basis, multiple lines of evidence have focused on the molecular pathways and cellular mechanisms involved in fibrosis, which has led to the development of novel antifibrotic therapies. CD248 is one of several proteins identified to be localized to the stromal compartment in cancers and fibroproliferative disease, and may serve a key role in myofibroblast generation and accumulation. Numerous studies have supported the contribution of CD248 to tumour growth and fibrosis, stimulating interest in this molecule as a therapeutic target. In addition, it has been revealed that CD248 may be involved in pathological angiogenesis. The present review describes the current understanding of the structure and function of CD248 during angiogenesis and fibrosis, supporting the hypothesis that blocking CD248 signalling may prevent both myofibroblast generation and microvascular alterations during tissue fibrosis. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Medicine Reports is the property of Spandidos Publications UK Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target.
|
---|---|
Autor/in / Beteiligte Person: | Di Benedetto, Paola ; Ruscitti, Piero ; Liakouli, Vasiliki ; Del Galdo, Francesco ; Giacomelli, Roberto ; Cipriani, Paola |
Zeitschrift: | Molecular Medicine Reports, Jg. 20 (2019-08-01), Heft 2, S. 1488-1498 |
Veröffentlichung: | 2019 |
Medientyp: | academicJournal |
ISSN: | 1791-2997 (print) |
DOI: | 10.3892/mmr.2019.10429 |
Schlagwort: |
|
Sonstiges: |
|